ArticlePharmaceutics2019

Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.

Rajiv Bajracharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.